Compare · PXMD vs USNA
PXMD vs USNA
Side-by-side comparison of PaxMedica Inc. (PXMD) and USANA Health Sciences Inc. (USNA): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both PXMD and USNA operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- USNA carries a market cap of $1.86B.
- Over the past year, PXMD is up 0.0% and USNA is down 29.5% - PXMD leads by 29.5 points.
- USNA has hit the wire 2 times in the past 4 weeks while PXMD has been quiet.
- USNA has more recent analyst coverage (3 ratings vs 0 for PXMD).
- Company
- PaxMedica Inc.
- USANA Health Sciences Inc.
- Price
- $0.72-3.73%
- $19.42+0.78%
- Market cap
- -
- $1.86B
- 1M return
- +0.00%
- +12.65%
- 1Y return
- +0.00%
- -29.54%
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NASDAQ
- NYSE
- IPO
- 2022
- News (4w)
- 0
- 2
- Recent ratings
- 0
- 3
USANA Health Sciences Inc.
USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional and personal care products. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers comprising targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and foods that include meal replacement shakes, snack bars, and other related products, which provide macro-nutrition. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products directly in the Asia Pacific, the Americas, and Europe, as well as online. The company has a research collaboration agreement with Beijing University of Chinese Medicine for research in the field of traditional Chinese medicine. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.
Latest PXMD
- PaxMedica Inc. filed SEC Form 8-K: Leadership Update
- PaxMedica Announces First Patent Allowance for Suramin Intranasal Formulation in the treatment of Autism Spectrum Disorder and Other Conditions
- Amendment: SEC Form SC 13G/A filed by PaxMedica Inc.
- SEC Form NT 10-Q filed by PaxMedica Inc.
- SEC Form EFFECT filed by PaxMedica Inc.
- SEC Form S-1 filed by PaxMedica Inc.
- SEC Form 10-Q filed by PaxMedica Inc.
- PaxMedica Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Material Modification to Rights of Security Holders, Financial Statements and Exhibits
- PaxMedica Secures Immediate Exercise of Warrants
- PaxMedica Reports First Patient Treated with PAX-101 for Fatal African Sleeping Sickness Infection
Latest USNA
- USANA Schedules First Quarter 2026 Earnings Release and Conference Call
- SEC Form DEF 14A filed by USANA Health Sciences Inc.
- USANA CEO Kevin Guest Calls for Daily Health Routines on World Health Day
- Amendment: SEC Form SCHEDULE 13G/A filed by USANA Health Sciences Inc.
- Tested, Trusted, Approved: USANA CellSentials Earns ConsumerLab.com Seal of Approval for Purity and Potency
- SEC Form 4 filed by Fuller Gilbert A
- SEC Form 10-K filed by USANA Health Sciences Inc.
- Next-Generation Platforms Scale Across Energy, Wellness, and Smokeless Consumer Segments
- CHIEF INFORMATION OFFICER Benedict Peter sold $88,259 worth of shares (4,553 units at $19.38), closing all direct ownership in the company (SEC Form 4)
- SEC Form 144 filed by USANA Health Sciences Inc.